One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1182/blood.v128.22.2993.2993
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Dec 2, 2016 |
 Citations: 5 |
Affiliation: The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, University of Alabama at Birmingham, Washington University in St. Louis, Stanford Medicine, Fox Chase Cancer Center, City Of Hope National Medical Center, University of Southampton, The Christie Hospital, Seagen (United States), Millennium Engineering and Integration (United States), Takeda (United States), University of Washington Medical Center
Four-Year Survival and Durability Results of Brentuximab Vedotin in Combination with CHP in the Frontline Treatment of Patients with CD30-Expressing Peripheral T-Cell Lymphomas
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
